USILNETUG
UNII ZAP3NVN6ZB

Substance Identification & Data

This profile provides standardized clinical and technical data for Usilnetug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZAP3NVN6ZB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2770861-19-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZAP3NVN6ZB

CAS Registry Number

2770861-19-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

USILNETUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203161

National Cancer Institute reference terminology for clinical and research data.

INN ID

12743

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-38

Identifier assigned by the United States Adopted Names Council.

Substance Type

Usilnetug

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Usilnetug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Usilnetug

Common Names & Synonyms

Immunoglobulin G1, anti-(human amyloid β) (human-Mus musculus monoclonal PR-1905069 γ1-chain), disulfide with human-Mus musculus monoclonal PR-1905069 κ-chain, dimer

Immunoglobulin G1-kappa, anti-[Homo sapiens APP (amyloid beta A4 precursor protein) Abeta N3pGlu (amyloid beta N-terminal truncated and pyroglutamate modified at position 3, AβpE3) peptides], monoclonal antibody; gamma1 heavy chain (1-451) [VH Musmus/Homsap (Mus musculus IGHV8-12*01 (82.0%) -(IGHD) -IGHJ3*01 (92.9%) A128>S (121)/Homo sapiens IGHV2-5*08 (75.0%) -(IGHD) -IGHJ4*01 (92.9%), CDR-IMGT [10.7.13] (26-35.53-59.98-110)) (1-121) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (218) (122-219), hinge 1-15 (220-234), CH2 (235-344), CH3 E12 (360), M14 (362) (345-449), CHS (450-451)) (122-451)], (224-214')-disulfide with kappa light chain (1'-214') [V-KAPPA (Homo sapiens IGKV1-12*01 (88.4%) -IGKJ2*02 (100%), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01 (100%), Km3, A45.1 (153'), V101 (191') (108'-214')]; dimer (230-230'':233-233'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, derived from the cell line CHO-K1, glycoform alfa

USILNETUG [USAN]

usilnetug [INN]